Your browser doesn't support javascript.
loading
TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype.
Ramos-Campoy, Silvia; Puiggros, Anna; Kamaso, Joanna; Beà, Sílvia; Bougeon, Sandrine; Larráyoz, María José; Costa, Dolors; Parker, Helen; Rigolin, Gian Matteo; Blanco, María Laura; Collado, Rosa; Ancín, Idoya; Salgado, Rocío; Moro-García, Marco A; Baumann, Tycho; Gimeno, Eva; Moreno, Carol; Salido, Marta; Calvo, Xavier; Calasanz, María José; Cuneo, Antonio; Nguyen-Khac, Florence; Oscier, David; Haferlach, Claudia; Strefford, Jonathan C; Schoumans, Jacqueline; Espinet, Blanca.
Afiliação
  • Ramos-Campoy S; Molecular Cytogenetics and Hematological Cytology Laboratories, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
  • Puiggros A; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Kamaso J; Molecular Cytogenetics and Hematological Cytology Laboratories, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
  • Beà S; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Bougeon S; Molecular Cytogenetics and Hematological Cytology Laboratories, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
  • Larráyoz MJ; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Costa D; Hematopathology Section, Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain.
  • Parker H; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Rigolin GM; Oncogenomic Laboratory, Hematology Service, Lausanne University Hospital, 1011 Lausanne, Switzerland.
  • Blanco ML; Cytogenetics and Hematological Genetics Services, Department of Genetics, University of Navarra, 31008 Pamplona, Spain.
  • Collado R; Hematopathology Section, Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain.
  • Ancín I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Salgado R; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
  • Moro-García MA; Hematology Section, St. Anna University Hospital, 44121 Ferrara, Italy.
  • Baumann T; Department of Hematology, Hospital de la Santa Creu I Sant Pau, 08041 Barcelona, Spain.
  • Gimeno E; Department of Hematology, Consorcio Hospital General Universitario, 46014 Valencia, Spain.
  • Moreno C; Department of Hematology and Hemotherapy, Hospital Universitario Cruces, 48903 Bilbao, Spain.
  • Salido M; Cytogenetics Laboratory, Hematology Department, Fundación Jiménez Díaz, 28040 Madrid, Spain.
  • Calvo X; Laboratory Medicine Department, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
  • Calasanz MJ; Hematopathology Section, Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain.
  • Cuneo A; Molecular Cytogenetics and Hematological Cytology Laboratories, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
  • Nguyen-Khac F; Applied Clinical Research in Hematological Malignances, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Oscier D; Department of Hematology, Hospital de la Santa Creu I Sant Pau, 08041 Barcelona, Spain.
  • Haferlach C; Molecular Cytogenetics and Hematological Cytology Laboratories, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
  • Strefford JC; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Schoumans J; Molecular Cytogenetics and Hematological Cytology Laboratories, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
  • Espinet B; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
Cancers (Basel) ; 14(15)2022 Jul 29.
Article em En | MEDLINE | ID: mdl-35954380
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article